Showing results (111-120 of 262) with videos related to

Sort By:
Pageof 27
Discover Oncology|July 19, 2023
Evolving therapeutic landscape of diffuse large B-cell lymphoma: challenges and aspirationsJason Yongsheng Chan, Nagavalli Somasundaram, Nicholas Grigoropoulos, et al.
Angewandte Chemie (International Ed. in English)|November 2, 2021
Tumor-Cell-Specific Targeting of Ibrutinib: Introducing Electrostatic Antibody-Inhibitor Conjugates (AiCs)Andreas Faust, Nicole Bäumer, Alina Schlütermann, et al.
Frontiers in Cell and Developmental Biology|August 22, 2025
Prognostic marker Musashi-2 modulates DNA damage response and radioresistance in diffuse large B-cell lymphomaTimo Habig, Lasse Reichstein, Kathrin A Brücksken, et al.
Blood Advances|September 24, 2021
Calcitonin receptor-like (CALCRL) is a marker of stemness and an independent predictor of outcome in pediatric AMLLinus Angenendt, Marius Wöste, Jan-Henrik Mikesch, et al.
Frontiers in Oncology|July 30, 2026
Case report: Eosinophilia as a rare symptom and primary sign of acute lymphoblastic leukemia with translocation (5;14)(q31;q32)Pearl van Heteren, Franziska Westendorf, Emin Abdullayev, et al.
Annals of Hematology|September 3, 2021
The role of autologous stem cell transplantation (ASCT) in aggressive B-cell lymphomas: real-world data from a retrospective single-center analysisRamona Wullenkord, Philipp Berning, Anna-Lena Niemann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 17, 2026
Ro 08-2750 increases radiation-induced cytotoxicity in DLBCL by dysregulating the DNA damage responseLasse Reichstein, Timo Habig, Kathrin A Gurke Brücksken, et al.
British Journal of Haematology|December 7, 2018
Doubling rituximab in high-risk patients with aggressive B-cell lymphoma -results of the DENSE-R-MegaCHOEP trialBirte Friedrichs, Maike Nickelsen, Marita Ziepert, et al.
British Journal of Haematology|June 9, 2020
Low-density lipoprotein receptor (LDLR) is an independent adverse prognostic factor in acute myeloid leukaemiaMatthias Floeth, Sandra Elges, Joachim Gerss, et al.
Cancers|May 16, 2023
Radiomics of Tumor Heterogeneity in 18F-FDG-PET-CT for Predicting Response to Immune Checkpoint Inhibition in Therapy-Naïve Patients with Advanced Non-Small-Cell Lung CancerDavid Ventura, Philipp Schindler, Max Masthoff, et al.
Pageof 27